BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19336690)

  • 1. Type 2 diabetes susceptibility gene TCF7L2 and its role in beta-cell function.
    Gloyn AL; Braun M; Rorsman P
    Diabetes; 2009 Apr; 58(4):800-2. PubMed ID: 19336690
    [No Abstract]   [Full Text] [Related]  

  • 2. TCF7L2 regulates late events in insulin secretion from pancreatic islet beta-cells.
    da Silva Xavier G; Loder MK; McDonald A; Tarasov AI; Carzaniga R; Kronenberger K; Barg S; Rutter GA
    Diabetes; 2009 Apr; 58(4):894-905. PubMed ID: 19168596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TCF7L2 and type 2 diabetes--we WNT to know.
    Smith U
    Diabetologia; 2007 Jan; 50(1):5-7. PubMed ID: 17102948
    [No Abstract]   [Full Text] [Related]  

  • 4. The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus.
    Jin T; Liu L
    Mol Endocrinol; 2008 Nov; 22(11):2383-92. PubMed ID: 18599616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prime suspect: the TCF7L2 gene and type 2 diabetes risk.
    Hattersley AT
    J Clin Invest; 2007 Aug; 117(8):2077-9. PubMed ID: 17671643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCF7L2 polymorphisms modulate proinsulin levels and beta-cell function in a British Europid population.
    Loos RJ; Franks PW; Francis RW; Barroso I; Gribble FM; Savage DB; Ong KK; O'Rahilly S; Wareham NJ
    Diabetes; 2007 Jul; 56(7):1943-7. PubMed ID: 17416797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance.
    Damcott CM; Pollin TI; Reinhart LJ; Ott SH; Shen H; Silver KD; Mitchell BD; Shuldiner AR
    Diabetes; 2006 Sep; 55(9):2654-9. PubMed ID: 16936218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCF7L2 controls insulin gene expression and insulin secretion in mature pancreatic beta-cells.
    Loder MK; da Silva Xavier G; McDonald A; Rutter GA
    Biochem Soc Trans; 2008 Jun; 36(Pt 3):357-9. PubMed ID: 18481957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes.
    Lyssenko V; Lupi R; Marchetti P; Del Guerra S; Orho-Melander M; Almgren P; Sjögren M; Ling C; Eriksson KF; Lethagen AL; Mancarella R; Berglund G; Tuomi T; Nilsson P; Del Prato S; Groop L
    J Clin Invest; 2007 Aug; 117(8):2155-63. PubMed ID: 17671651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loci of TCF7L2, HHEX and IDE on chromosome 10q and the susceptibility of their genetic polymorphisms to type 2 diabetes.
    Nordman S; Ostenson CG; Efendic S; Gu HF
    Exp Clin Endocrinol Diabetes; 2009 Apr; 117(4):186-90. PubMed ID: 19053027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.
    Villareal DT; Robertson H; Bell GI; Patterson BW; Tran H; Wice B; Polonsky KS
    Diabetes; 2010 Feb; 59(2):479-85. PubMed ID: 19934000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No major contribution of TCF7L2 sequence variants to maturity onset of diabetes of the young (MODY) or neonatal diabetes mellitus in French white subjects.
    Cauchi S; Vaxillaire M; Choquet H; Durand E; Duval A; Polak M; Froguel P
    Diabetologia; 2007 Jan; 50(1):214-6. PubMed ID: 17093940
    [No Abstract]   [Full Text] [Related]  

  • 13. Translating TCF7L2: from gene to function.
    Pearson ER
    Diabetologia; 2009 Jul; 52(7):1227-30. PubMed ID: 19387612
    [No Abstract]   [Full Text] [Related]  

  • 14. Transcription factor 7-like 2 polymorphisms and type 2 diabetes, glucose homeostasis traits and gene expression in US participants of European and African descent.
    Elbein SC; Chu WS; Das SK; Yao-Borengasser A; Hasstedt SJ; Wang H; Rasouli N; Kern PA
    Diabetologia; 2007 Aug; 50(8):1621-30. PubMed ID: 17579832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCF7L2: the biggest story in diabetes genetics since HLA?
    Zeggini E; McCarthy MI
    Diabetologia; 2007 Jan; 50(1):1-4. PubMed ID: 17096114
    [No Abstract]   [Full Text] [Related]  

  • 16. The transcription factor 7-like 2 gene and increased risk of type 2 diabetes: an update.
    Lyssenko V
    Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):385-92. PubMed ID: 18541996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A genetic variation of the transcription factor 7-like 2 gene is associated with risk of type 2 diabetes in the Japanese population.
    Horikoshi M; Hara K; Ito C; Nagai R; Froguel P; Kadowaki T
    Diabetologia; 2007 Apr; 50(4):747-51. PubMed ID: 17245589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TCF7L2 genetic defect and type 2 diabetes.
    Cauchi S; Froguel P
    Curr Diab Rep; 2008 Apr; 8(2):149-55. PubMed ID: 18445358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of variants of transcription factor 7-like 2 (TCF7L2) with susceptibility to type 2 diabetes in the Dutch Breda cohort.
    van Vliet-Ostaptchouk JV; Shiri-Sverdlov R; Zhernakova A; Strengman E; van Haeften TW; Hofker MH; Wijmenga C
    Diabetologia; 2007 Jan; 50(1):59-62. PubMed ID: 17031610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCF7L2 genetic variants and progression to diabetes in the Chinese population: pleiotropic effects on insulin secretion and insulin resistance.
    Chang YC; Chiu YF; Ho LL; Ting CT; Shih KC; Curb JD; Chen YD; Li HY; Chuang LM
    J Mol Med (Berl); 2010 Feb; 88(2):183-92. PubMed ID: 19806338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.